Prospective follow‐up of overactive bladder symptoms in patients with prior SARS‐CoV‐2 infection

Documenti analoghi

• Black box in overactive bladder: Central sensitization and its relationship with urinary symptom severity and quality of life
  di: Seyda T. Celenay, et al.
  Pubblicazione: (2024)
• Risk factors associated with overactive bladder severity in patients with type 2 diabetes
  di: Fater A. Khadour, et al.
  Pubblicazione: (2024)
• The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder
  di: Anne P. Cameron, et al.
  Pubblicazione: (2024)
• Fragility of overactive bladder medication clinical trials: A systematic review
  di: Kevin D. Li, et al.
  Pubblicazione: (2024)
• Patient and physician decision‐making dynamics in overactive bladder care: A mixed methods study
  di: Hannah M. Sitto, et al.
  Pubblicazione: (2024)